GEN Exclusives

More »

GEN News Highlights

More »
Sep 10, 2007

Advanced BioNutrition Wins DoD Contract to Advance Shrimp-Based Production Platform

  • Advanced BioNutrition (ABN) was awarded a $1.7 million contract from the DoD for the first phase of development of a shrimp-based production system for vaccines and mAbs.

    The contracts from the Defense Advanced Research Projects Agency (DARPA) and the Defense Threat Reduction Agency (DTRA) could reach $5.9 million over 42 months if all phases of the agreement are completed successfully, according to the company.

    Arun K. Dhar, Ph.D., a molecular virologist at ABN will be leading the three-phase program with a goal of producing three million doses of vaccine or immunological-based therapeutic within 12 weeks of the first recognition of a new pathogen, ABN reports.

    During the first phase of the contract, ABN plans to validate the use of crustaceans as biofactories using its transfection technology. The company reports that it is also developing a high-density GMP-capable production system for shrimp cultivation as well as methods for the isolation and purification of the final products.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »